MedPath

Effect of Xushan Qingfei Mixture on chronic lung disease

Not Applicable
Recruiting
Conditions
Chronic lung disease
Registration Number
ITMCTR2100004787
Lead Sponsor
Second Xiangya hospital of Central South University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Moderate and severe COPD patients: according to the diagnostic criteria of COPD in the guidelines for diagnosis and treatment of COPD issued by GOLD 2019;
2.Sign informed consent;
3.No communication barrier, can cooperate with medical history collection, and good compliance, cooperate with treatment.

Exclusion Criteria

1.Combined with other serious cardiopulmonary diseases, such as interstitial lung disease, severe asthma, severe pneumonia, tuberculosis, lung cancer, rheumatic heart disease, congenital heart disease, etc;
2.Patients with severe liver and kidney diseases;
3.Failure to use drugs according to regulations, inability to determine curative effect or incomplete information, etc. affect the judgment of curative effect or safety.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Inflammatory markers;Induced sputum;pulmonary function;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath